Vanqua Bio, a Chicago-based biopharmaceutical company, has raised $85 million in Series B financing. Omega Funds led the round with participation from other backers that included OrbiMed, Surveyor Capital, Avoro Ventures, Casdin Capital, Pontifax, Eli Lilly and Company, Logos Capital, and Osage University Partners.
Source: Press Release
If you do not receive this within five minutes, please try and sign in again. If the problem persists, please
email: